Similar articles

• [The thalidomide story: the Israeli chapter].

  Dolev E. Dolev E. Harefuah. 2001 Aug;140(8):795-7. Harefuah. 2001. PMID: 11547491 Hebrew. No abstract available.
• [New indications for thalidomide?].

  Tuinmann G, Hegewisch-Becker S, Hossfeld DK. Tuinmann G, et al. Dtsch Med Wochenschr. 2001 Oct 19;126(42):1178-82. doi: 10.1055/s-2001-17892. Dtsch Med Wochenschr. 2001. PMID: 11607859 Review. German. No abstract available.
• [Reinventing thalidomide under high supervision].

  Monneret C. Monneret C. Ann Pharm Fr. 2010 May;68(3):133-5. doi: 10.1016/j.pharma.2010.05.001. Ann Pharm Fr. 2010. PMID: 20569769 French. No abstract available.
• [Thalidomide: an unfinished history].

  Papaseit E, García-Algar O, Farré M. Papaseit E, et al. An Pediatr (Barc). 2013 May;78(5):283-7. doi: 10.1016/j.anpedi.2012.11.022. Epub 2013 Jan 16. An Pediatr (Barc). 2013. PMID: 23333198 Spanish. No abstract available.
• Teratogen update: thalidomide: a review, with a focus on ocular findings and new potential uses.

  Miller MT, Strömland K. Miller MT, et al. Teratology. 1999 Nov;60(5):306-21. doi: 10.1002/(SICI)1096-9926(199911)60:5<306::AID-TERA11>3.0.CO;2-Y. Teratology. 1999. PMID: 10525208 Review. No abstract available.